相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis
Aldo J. Montano-Loza et al.
LIVER INTERNATIONAL (2012)
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes
A. M. C. Baven-Pronk et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience
M. M. Tannous et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
An Additional Patient with Mycophenolate Mofetil Embryopathy: Cardiac and Facial Analyses
Angela E. Lin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Budesonide for the Treatment of Autoimmune Hepatitis
Kenneth R. Snider et al.
ANNALS OF PHARMACOTHERAPY (2011)
Autoimmune hepatitis in special patient populations
Albert J. Czaja
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Immunosuppressive Therapy Allows Recovery From Liver Failure in Children With Autoimmune Hepatitis
Miriam L. Cuarterolo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Albert J. Czaja
CURRENT PHARMACEUTICAL DESIGN (2011)
Therapeutic Strategies for Autoimmune Hepatitis
Michael P. Manns et al.
DIGESTIVE DISEASES (2011)
Autoimmune Hepatitis: The Dilemma of Rare Diseases
Michael P. Manns
GASTROENTEROLOGY (2011)
Early Predictors of Corticosteroid Treatment Failure in Icteric Presentations of Autoimmune Hepatitis
Andrew D. Yeoman et al.
HEPATOLOGY (2011)
Mycophenolate for the treatment of autoimmune hepatitis: Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients
Kalliopi Zachou et al.
JOURNAL OF HEPATOLOGY (2011)
Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment
Ansgar W. Lohse et al.
JOURNAL OF HEPATOLOGY (2011)
Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy
Hind I. Fallatah et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis
Betsy Adams et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy
Kaveh Sharzehi et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Molecular aspects of cyclophilins mediating therapeutic actions of their ligands
Andrzej Galat et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib
Dhimant Desai et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Autoantibodies as Prognostic Markers in Autoimmune Liver Disease
Albert J. Czaja
DIGESTIVE DISEASES AND SCIENCES (2010)
Emerging Opportunities for Site-Specific Molecular and Cellular Interventions in Autoimmune Hepatitis
Albert J. Czaja
DIGESTIVE DISEASES AND SCIENCES (2010)
Late Relapse of Type 1 Autoimmune Hepatitis After Corticosteroid Withdrawal
Albert J. Czaja
DIGESTIVE DISEASES AND SCIENCES (2010)
Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis
Michael P. Manns et al.
GASTROENTEROLOGY (2010)
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Albert J. Czaja et al.
GASTROENTEROLOGY (2010)
Diagnosis and Management of Autoimmune Hepatitis
Michael P. Manns et al.
HEPATOLOGY (2010)
SLA/LP/tRNP(Ser)Sec antigen in autoimmune hepatitis: Identification of the native protein in human hepatic cell extract
Martin Volkmann et al.
JOURNAL OF AUTOIMMUNITY (2010)
N-Acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms
Chantal Bemeur et al.
METABOLIC BRAIN DISEASE (2010)
Cyclosporine Inhibits Profibrotic Effects of Interleukin-4 and Transforming Growth Factor β on Human Intrahepatic Fibroblasts Cultured In Vitro
A. Pissaia et al.
TRANSPLANTATION PROCEEDINGS (2010)
Difficult treatment decisions in autoimmune hepatitis
Albert J. Czaja
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Prenatal Exposure to Mycophenolate Mofetil: An Updated Estimate
Chagit Klieger-Grossmann et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2010)
Reviewing the Evidence for Mycophenolate Mofetil as a New Teratogen: Case Report and Review of the Literature
Marlene T. Anderka et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Calcineurin activation by slow calcium release from intracellular stores suppresses protein kinase C regulation of L-type calcium channels in L6 cells
Jay D. Turner et al.
CELL CALCIUM (2009)
Mycophenolate Mofetil for Autoimmune Hepatitis: A Single Practice Experience
David C. Wolf et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Mycophenolate mofetil to the rescue in autoimmune hepatitis: A fresh sprout on the decision tree
Albert J. Czaja
JOURNAL OF HEPATOLOGY (2009)
Rapidity of treatment response and outcome in type 1 autoimmune hepatitis
Albert J. Czaja
JOURNAL OF HEPATOLOGY (2009)
Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: A 5-year follow-up
Marion M. Aw et al.
JOURNAL OF HEPATOLOGY (2009)
Significance of antibodies to soluble liver antigen/liver pancreas: a large French study
Violaine Eyraud et al.
LIVER INTERNATIONAL (2009)
Features and consequences of untreated type 1 autoimmune hepatitis
Albert J. Czaja
LIVER INTERNATIONAL (2009)
Special Clinical Challenges in Autoimmune Hepatitis: The Elderly, Males, Pregnancy, Mild Disease, Fulminant Onset, and Nonwhite Patients
Albert J. Czaja
SEMINARS IN LIVER DISEASE (2009)
New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation
Hylke de Jonge et al.
THERAPEUTIC DRUG MONITORING (2009)
Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment
Albert I. Czaja et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Current and future treatments of autoimmune hepatitis
Albert J Czaja
Expert Review of Gastroenterology & Hepatology (2009)
Risk Factors for Chronic Liver Disease in Blacks, Mexican Americans, and Whites in the United States: Results From NHANES IV, 1999-2004
Yvonne N. Flores et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?
Elke M. Hennes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Autoimmune hepatitis in a North American Aboriginal/First Nations population
G. Y. Minuk et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
The use of budesonide in the treatment of autoimmune hepatitis in Canada
Iman Zandieh et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis
Jonathan T. Hlivko et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis
Albert J. Czaja
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Safety issues in the management of autoimmune hepatitis
Albert J. Czaja
EXPERT OPINION ON DRUG SAFETY (2008)
Identification of CD4 T-Cell Epitopes in Soluble Liver Antigen/Liver Pancreas Autoantigen in Autoimmune Hepatitis
Heiko Mix et al.
GASTROENTEROLOGY (2008)
Racial disparity in liver disease: Biological, cultural, or socioeconomic factors
Geoffrey C. Nguyen et al.
HEPATOLOGY (2008)
Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis
Maria Serena Longhi et al.
HEPATOLOGY (2008)
CTLA-4: a key regulatory point in the control of autoimmune disease
Kenneth J. Scalapino et al.
IMMUNOLOGICAL REVIEWS (2008)
Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis
Stefan Lueth et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Favorable outcomes of autoimmune hepatitis in a community clinic setting
Suk Seo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
In utero exposure to mycophenolate mofetil: A characteristic phenotype?
Antonio Perez-Aytes et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
The impact of ethnicity on the natural history of autoimmune hepatitis
Sumita Verma et al.
HEPATOLOGY (2007)
Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease
Aldo J. Montano-Loza et al.
HEPATOLOGY (2007)
Long-term prognosis in patients with severe late radiation enteropathy: A prospective cohort study
Annette Larsen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy
Ira Inductivo-Yu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: A national study
Geoffrey C. Nguyen et al.
HEPATOLOGY (2007)
Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse
Aldo J. Montano-Loza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Consequences of treatment withdrawal in type 1 autoimmune hepatitis
Aldo J. Montano-Loza et al.
LIVER INTERNATIONAL (2007)
CD4+CD25+ T regulatory cells and TGF-β in mucosal immune system:: The good and the bad
WanJun Chen et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C
Paolo Muratori et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Antibody responses specific for soluble liver antigen co-occur with RO-52 autoantibodies in patients with autoimmune hepatitis
C. Liaskos et al.
JOURNAL OF HEPATOLOGY (2007)
Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics
Kazuhide Iwasaki
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Follow-up of children with autoimmune hepatitis treated with cyclosporine
Miriam Cuarterolo et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study
A. Floreani et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
T-cell-targeted therapies in rheumatoid arthritis
CM Weyand et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis
Maria Serena Longhi et al.
JOURNAL OF IMMUNOLOGY (2006)
Budesonide induces complete remission in autoimmune hepatitis
Antal Csepregi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly
AJ Czaja et al.
HEPATOLOGY (2006)
Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells
N Nikolaeva et al.
TRANSPLANTATION (2006)
Cost-effectiveness of pharmacotherapy for autoimmune hepatitis
MA Heneghan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Antifibrotic actions of mycophenolic acid
Christian Morath et al.
CLINICAL TRANSPLANTATION (2006)
Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis
Y Miyake et al.
JOURNAL OF HEPATOLOGY (2005)
Budesonide in previously untreated autoimmune hepatitis
J Wiegand et al.
LIVER INTERNATIONAL (2005)
Empiric therapy of autoimmune hepatitis with mycophenolate mofetil - Comparison with conventional treatment for refractory disease
AJ Czaja et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition
MJJ Ronis et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy
S Seela et al.
LIVER INTERNATIONAL (2005)
Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus
N Chatur et al.
LIVER INTERNATIONAL (2005)
Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome
JJ Feld et al.
HEPATOLOGY (2005)
NFAT proteins: Key regulators of T-cell development and function
F Macian
NATURE REVIEWS IMMUNOLOGY (2005)
A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
KC Herold et al.
DIABETES (2005)
Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine
NKH de Boer et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
An unusual form of autoimmune hepatitis in young Somalian men
R D'Souza et al.
LIVER INTERNATIONAL (2005)
Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis
M Mohamadnejad et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Treatment challenges and Investigational opportunities in autoimmune hepatitis
AJ Czaja et al.
HEPATOLOGY (2005)
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy
SM Devlin et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Inhibitors of the calcineurin/NFAT pathway
S Martínez-Martínez et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis
AJ Czaja et al.
JOURNAL OF HEPATOLOGY (2004)
Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis
BA Aqel et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Factors predicting relapse and poor outcome in type I autoimmune hepatitis: Role of cirrhosis development, patterns of transaminases during remission, and plasma cell activity in the liver biopsy
S Verma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Anti-CD3 antibodies: towards clinical antigen -specific immunomodulation
L Chatenoud
CURRENT OPINION IN PHARMACOLOGY (2004)
NFAT and NF-κB factors -: the distant relatives
E Serfling et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
MS Longhi et al.
JOURNAL OF HEPATOLOGY (2004)
Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay
H Miyakawa et al.
JOURNAL OF AUTOIMMUNITY (2003)
Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis
AJ Czaja et al.
LIVER INTERNATIONAL (2003)
Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus
KA Jorgensen et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis
AJ Czaja et al.
AUTOIMMUNITY (2002)
Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States
AJ Czaja et al.
JOURNAL OF HEPATOLOGY (2002)
Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics
M Baeres et al.
GUT (2002)
Diagnosis and treatment of autoimmune hepatitis
AJ Czaja et al.
HEPATOLOGY (2002)
Burden of liver disease in the United States: Summary of a workshop
WR Kim et al.
HEPATOLOGY (2002)
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin
T Zolfino et al.
GUT (2002)
Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysis
AJ Czaja et al.
HEPATOLOGY (2002)
Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic autoimmune diabetes without choriomeningitis virus) impeding viral clearance
MG von Herrath et al.
JOURNAL OF IMMUNOLOGY (2002)
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease
Y Ma et al.
HEPATOLOGY (2002)
Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis
R Malekzadeh et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient
M Hurtova et al.
LIVER TRANSPLANTATION (2001)
Protracted, but not acute, hepatitis a virus infection is strongly associated with HLA-DRB1*1301, a marker for pediatric autoimmune hepatitis
L Fainboim et al.
HEPATOLOGY (2001)
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex
JCD Schwartz et al.
NATURE (2001)
Soluble liver antigen:: Isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis
M Volkmann et al.
HEPATOLOGY (2001)
Duration of immunosuppressive therapy in autoimmune hepatitis
S Kanzler et al.
JOURNAL OF HEPATOLOGY (2001)
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
AJ Czaja et al.
GASTROENTEROLOGY (2000)
Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients with type-1 autoimmune hepatitis
M Costa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Mycophenolate mofetil and its mechanisms of action
AC Allison et al.
IMMUNOPHARMACOLOGY (2000)
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
I Wies et al.
LANCET (2000)
Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine
PD Richardson et al.
JOURNAL OF HEPATOLOGY (2000)
分享论文
